In studies on CTRP9 KO mice [21] and transgenic CTRP9 mice [9], results showed that pharmacologically elevated circulating CTRP9 exerted therapeutic effects on the obesity and obesity-associated insulin resistance. Here, C1QTNF9 is linked to obesity due to melanocortin 4 receptor deficiency.